Connecticut House Bill HB05119

Connecticut 2021 Regular Session

• Introduced: 1/12/21
• Refer: 1/12/21

Caption

An Act Concerning Health Insurance Coverage For Prescription Drugs.

Impact

If passed, HB05119 would significantly impact health insurance policies in the state by stabilizing the coverage landscape for prescription drugs. It would prevent health insurers from making mid-term alterations that could restrict access or increase out-of-pocket expenses for patients relying on specific medications. This measure aims to provide greater transparency and predictability in the health insurance market, which could influence how policies are structured and marketed by insurers.

Summary

House Bill 05119, titled 'An Act Concerning Health Insurance Coverage for Prescription Drugs,' seeks to amend state insurance regulations regarding the coverage and pricing of prescription medications. The bill stipulates that health carriers providing coverage must not remove any covered prescription drug from their lists, nor reclassify them to a higher cost-sharing tier during the effective term of the policy. This legislation aims to enhance patient protection and ensure that individuals maintain access to previously covered medications without facing unexpected increases in costs.

Contention

The discussions surrounding the bill highlight potential contention, particularly from insurance providers who may view the restrictions as overly burdensome. Critics could argue that such mandates limit their ability to manage costs and could lead to increased premiums as insurers cope with the inability to adjust their drug coverage strategies. Opponents might also express concerns about the implications for formularies and drug market competition, which might affect availability and innovation in drug offerings.